BAY 41-2272: a potential pharmacological tool for treating phagocyte disorders (2008)
Source: Clinical and Experimental Immunology. Conference titles: Meeting of the European Society for Immunology. Unidade: ICB
Assunto: IMUNOLOGIA
ABNT
PEREIRA, P. V. S. et al. BAY 41-2272: a potential pharmacological tool for treating phagocyte disorders. Clinical and Experimental Immunology. London: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 01 out. 2024. , 2008APA
Pereira, P. V. S., Falcai, A., Oliveira-Junior, E. B., Aragão-Filho, W. C., Frazão, J. B., Marques, O. C., et al. (2008). BAY 41-2272: a potential pharmacological tool for treating phagocyte disorders. Clinical and Experimental Immunology. London: Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Pereira PVS, Falcai A, Oliveira-Junior EB, Aragão-Filho WC, Frazão JB, Marques OC, Kubo CA, Errante PR, Antunes E, Condino-Neto A. BAY 41-2272: a potential pharmacological tool for treating phagocyte disorders. Clinical and Experimental Immunology. 2008 ; 154[citado 2024 out. 01 ]Vancouver
Pereira PVS, Falcai A, Oliveira-Junior EB, Aragão-Filho WC, Frazão JB, Marques OC, Kubo CA, Errante PR, Antunes E, Condino-Neto A. BAY 41-2272: a potential pharmacological tool for treating phagocyte disorders. Clinical and Experimental Immunology. 2008 ; 154[citado 2024 out. 01 ]